These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 29961117)

  • 1. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment.
    Munier FL; Mosimann P; Puccinelli F; Gaillard MC; Stathopoulos C; Houghton S; Bergin C; Beck-Popovic M
    Br J Ophthalmol; 2017 Aug; 101(8):1086-1093. PubMed ID: 27927678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
    Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
    BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
    Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
    Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
    Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):723-730. PubMed ID: 32123960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
    Selzer EB; Welch RJ; Jabbour P; Leahey AM; Shields CL
    Indian J Ophthalmol; 2019 Dec; 67(12):2005-2011. PubMed ID: 31755439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
    Mirzayev I; Gündüz AK; Yavuz K; Şekkeli MZ; Özalp Ateş FS; Ünal E; Taçyıldız N
    Eur J Ophthalmol; 2021 Sep; 31(5):2692-2698. PubMed ID: 32962409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma.
    Shields CL; Jorge R; Say EA; Magrath G; Alset A; Caywood E; Leahey AM; Jabbour P; Shields JA
    Asia Pac J Ophthalmol (Phila); 2016; 5(2):97-103. PubMed ID: 26765038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
    Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
    Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.
    Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Huang W; Jiang H; Xia J; Zhang S
    BMC Cancer; 2018 Apr; 18(1):486. PubMed ID: 29703164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Globe salvage treatment in group D and group E retinoblastoma.
    Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
    Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.